BC
RETA

Brookfield Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Brookfield Corp’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-55,201
Closed -$5.02M – 774
2023
Q1 		$5.02M Buy
+55,201
New +$5.02M 0.02% 282